Reduced bone density at completion of chemotherapy for a malignancy

Citation
P. Arikoski et al., Reduced bone density at completion of chemotherapy for a malignancy, ARCH DIS CH, 80(2), 1999, pp. 143-148
Citations number
43
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
ARCHIVES OF DISEASE IN CHILDHOOD
ISSN journal
00039888 → ACNP
Volume
80
Issue
2
Year of publication
1999
Pages
143 - 148
Database
ISI
SICI code
0003-9888(199902)80:2<143:RBDACO>2.0.ZU;2-N
Abstract
Objectives-Osteoporosis and pathological fractures occur occasionally in ch ildren with malignancies. This study was performed to determine the degree of osteopenia in children with a malignancy at completion of chemotherapy. Methods-Lumbar spine (L2-L4) bone mineral density (BMD; g/cm(2)) and femora l neck BMD were measured by dual energy x ray absorptiometry in 22 children with acute lymphoblastic leukaemia (ALL), and in 26 children with other ma lignancies. Apparent volumetric density was calculated to minimise the effe ct of bone size on BMD. Results were compared with those of 113 healthy con trols and expressed as age and sex standardised mean Z scores. Results-Patients with ALL had significantly reduced lumbar volumetric (-0.7 7) and femoral areal and volumetric BMDs (-1.02 and -0.98, respectively). I n patients with other malignancies, femoral areal and apparent volumetric B MDs were significantly decreased (-0.70 and -0.78, respectively). Conclusions-The results demonstrate that children with a malignancy are at risk of developing osteopenia. A follow up of BMD after the completion of c hemotherapy should facilitate the identification of patients who might be l eft with impaired development of peak bone mass, and who require specific i nterventions to prevent any further decrease in their skeletal mass and to preserve their BMD.